Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is an often deadly complication of IPF. No focussed international guidelines for the management of AE-IPF exist. The aim of this international survey was to assess the global variability in prevention, diagnostic and treatment strategies f...
Gespeichert in:
| Veröffentlicht in: | The European respiratory journal 2020-04, Vol.55 (4), p.1901760 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 1901760 |
| container_title | The European respiratory journal |
| container_volume | 55 |
| creator | Kreuter, Michael Polke, Markus Walsh, Simon L F Krisam, Johannes Collard, Harold R Chaudhuri, Nazia Avdeev, Sergey Behr, Jürgen Calligaro, Gregory Corte, Tamera Flaherty, Kevin Funke-Chambour, Manuela Kolb, Martin Kondoh, Yasuhiro Maher, Toby M Molina Molina, Maria Morais, Antonio Moor, Catharina C Morisset, Julie Pereira, Carlos Quadrelli, Silvia Selman, Moises Tzouvelekis, Argyrios Valenzuela, Claudia Vancheri, Carlo Vicens-Zygmunt, Vanesa Wälscher, Julia Wuyts, Wim Wijsenbeek, Marlies Cottin, Vincent Bendstrup, Elisabeth |
| description | Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is an often deadly complication of IPF. No focussed international guidelines for the management of AE-IPF exist. The aim of this international survey was to assess the global variability in prevention, diagnostic and treatment strategies for AE-IPF.Pulmonologists with ILD expertise were invited to participate in a survey designed by an international expert panel.509 pulmonologists from 66 countries responded. Significant geographical variability in approaches to manage AE-IPF was found. Common preventive measures included antifibrotic drugs and vaccination. Diagnostic differences were most pronounced regarding use of Krebs von den Lungen-6 and viral testing, while high-resolution computed tomography, brain natriuretic peptide and D-dimer are generally applied. High-dose steroids are widely administered (94%); the use of other immunosuppressant and treatment strategies is highly variable. Very few (4%) responders never use immunosuppression. Antifibrotic treatments are initiated during AE-IPF by 67%. Invasive ventilation or extracorporeal membrane oxygenation are mainly used as a bridge to transplantation. Most physicians educate patients comprehensively on the severity of AE-IPF (82%) and consider palliative care (64%).Approaches to the prevention, diagnosis and treatment of AE-IPF vary worldwide. Global trials and guidelines to improve the prognosis of AE-IPF are needed. |
| doi_str_mv | 10.1183/13993003.01760-2019 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2355935592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2355935592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-f81233ac2c7156bee5c26066fdc0e0341ae241a77ad88ff34132332b146cc7333</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhoMobk5_gSC59KbzJGdNW-_G8AsG3uh1SdOERdpmJq24f2-6Dy-SwMvz5nAeQm4ZzBnL8YFhUSAAzoFlAhIOrDgj0zFNxvicTKEATFiBYkKuQvgCYGKB7JJMkIMAEPmU1Es19JrqX6m0r2RvXUedoba2biv7jVV0OzSt66TfUWMr74INj9R2vfbdnpYNDYP_0Tsqu5oq2TTUOE830seWDXvmmlwY2QR9c3xn5PP56WP1mqzfX95Wy3WiMIU-MTnjiFJxlbFUVFqnigsQwtQKNOCCSc3jlWWyznNjYoCR5xVbCKUyRJyR-8O_W---Bx36srVB6aaRnXZDKDmmaTEeHlE8oCquFLw25dbbNm5ZMihHveVJb7nXW456Y-vuOGCoWl3_d04-8Q-k2XZb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2355935592</pqid></control><display><type>article</type><title>Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kreuter, Michael ; Polke, Markus ; Walsh, Simon L F ; Krisam, Johannes ; Collard, Harold R ; Chaudhuri, Nazia ; Avdeev, Sergey ; Behr, Jürgen ; Calligaro, Gregory ; Corte, Tamera ; Flaherty, Kevin ; Funke-Chambour, Manuela ; Kolb, Martin ; Kondoh, Yasuhiro ; Maher, Toby M ; Molina Molina, Maria ; Morais, Antonio ; Moor, Catharina C ; Morisset, Julie ; Pereira, Carlos ; Quadrelli, Silvia ; Selman, Moises ; Tzouvelekis, Argyrios ; Valenzuela, Claudia ; Vancheri, Carlo ; Vicens-Zygmunt, Vanesa ; Wälscher, Julia ; Wuyts, Wim ; Wijsenbeek, Marlies ; Cottin, Vincent ; Bendstrup, Elisabeth</creator><creatorcontrib>Kreuter, Michael ; Polke, Markus ; Walsh, Simon L F ; Krisam, Johannes ; Collard, Harold R ; Chaudhuri, Nazia ; Avdeev, Sergey ; Behr, Jürgen ; Calligaro, Gregory ; Corte, Tamera ; Flaherty, Kevin ; Funke-Chambour, Manuela ; Kolb, Martin ; Kondoh, Yasuhiro ; Maher, Toby M ; Molina Molina, Maria ; Morais, Antonio ; Moor, Catharina C ; Morisset, Julie ; Pereira, Carlos ; Quadrelli, Silvia ; Selman, Moises ; Tzouvelekis, Argyrios ; Valenzuela, Claudia ; Vancheri, Carlo ; Vicens-Zygmunt, Vanesa ; Wälscher, Julia ; Wuyts, Wim ; Wijsenbeek, Marlies ; Cottin, Vincent ; Bendstrup, Elisabeth</creatorcontrib><description>Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is an often deadly complication of IPF. No focussed international guidelines for the management of AE-IPF exist. The aim of this international survey was to assess the global variability in prevention, diagnostic and treatment strategies for AE-IPF.Pulmonologists with ILD expertise were invited to participate in a survey designed by an international expert panel.509 pulmonologists from 66 countries responded. Significant geographical variability in approaches to manage AE-IPF was found. Common preventive measures included antifibrotic drugs and vaccination. Diagnostic differences were most pronounced regarding use of Krebs von den Lungen-6 and viral testing, while high-resolution computed tomography, brain natriuretic peptide and D-dimer are generally applied. High-dose steroids are widely administered (94%); the use of other immunosuppressant and treatment strategies is highly variable. Very few (4%) responders never use immunosuppression. Antifibrotic treatments are initiated during AE-IPF by 67%. Invasive ventilation or extracorporeal membrane oxygenation are mainly used as a bridge to transplantation. Most physicians educate patients comprehensively on the severity of AE-IPF (82%) and consider palliative care (64%).Approaches to the prevention, diagnosis and treatment of AE-IPF vary worldwide. Global trials and guidelines to improve the prognosis of AE-IPF are needed.</description><identifier>ISSN: 0903-1936</identifier><identifier>EISSN: 1399-3003</identifier><identifier>DOI: 10.1183/13993003.01760-2019</identifier><identifier>PMID: 32060068</identifier><language>eng</language><publisher>England</publisher><ispartof>The European respiratory journal, 2020-04, Vol.55 (4), p.1901760</ispartof><rights>Copyright ©ERS 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c350t-f81233ac2c7156bee5c26066fdc0e0341ae241a77ad88ff34132332b146cc7333</citedby><cites>FETCH-LOGICAL-c350t-f81233ac2c7156bee5c26066fdc0e0341ae241a77ad88ff34132332b146cc7333</cites><orcidid>0000-0002-5591-0955 ; 0000-0003-3837-1467 ; 0000-0001-8348-8651 ; 0000-0001-7324-0775 ; 0000-0002-1022-4783 ; 0000-0001-9648-3497</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32060068$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kreuter, Michael</creatorcontrib><creatorcontrib>Polke, Markus</creatorcontrib><creatorcontrib>Walsh, Simon L F</creatorcontrib><creatorcontrib>Krisam, Johannes</creatorcontrib><creatorcontrib>Collard, Harold R</creatorcontrib><creatorcontrib>Chaudhuri, Nazia</creatorcontrib><creatorcontrib>Avdeev, Sergey</creatorcontrib><creatorcontrib>Behr, Jürgen</creatorcontrib><creatorcontrib>Calligaro, Gregory</creatorcontrib><creatorcontrib>Corte, Tamera</creatorcontrib><creatorcontrib>Flaherty, Kevin</creatorcontrib><creatorcontrib>Funke-Chambour, Manuela</creatorcontrib><creatorcontrib>Kolb, Martin</creatorcontrib><creatorcontrib>Kondoh, Yasuhiro</creatorcontrib><creatorcontrib>Maher, Toby M</creatorcontrib><creatorcontrib>Molina Molina, Maria</creatorcontrib><creatorcontrib>Morais, Antonio</creatorcontrib><creatorcontrib>Moor, Catharina C</creatorcontrib><creatorcontrib>Morisset, Julie</creatorcontrib><creatorcontrib>Pereira, Carlos</creatorcontrib><creatorcontrib>Quadrelli, Silvia</creatorcontrib><creatorcontrib>Selman, Moises</creatorcontrib><creatorcontrib>Tzouvelekis, Argyrios</creatorcontrib><creatorcontrib>Valenzuela, Claudia</creatorcontrib><creatorcontrib>Vancheri, Carlo</creatorcontrib><creatorcontrib>Vicens-Zygmunt, Vanesa</creatorcontrib><creatorcontrib>Wälscher, Julia</creatorcontrib><creatorcontrib>Wuyts, Wim</creatorcontrib><creatorcontrib>Wijsenbeek, Marlies</creatorcontrib><creatorcontrib>Cottin, Vincent</creatorcontrib><creatorcontrib>Bendstrup, Elisabeth</creatorcontrib><title>Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation</title><title>The European respiratory journal</title><addtitle>Eur Respir J</addtitle><description>Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is an often deadly complication of IPF. No focussed international guidelines for the management of AE-IPF exist. The aim of this international survey was to assess the global variability in prevention, diagnostic and treatment strategies for AE-IPF.Pulmonologists with ILD expertise were invited to participate in a survey designed by an international expert panel.509 pulmonologists from 66 countries responded. Significant geographical variability in approaches to manage AE-IPF was found. Common preventive measures included antifibrotic drugs and vaccination. Diagnostic differences were most pronounced regarding use of Krebs von den Lungen-6 and viral testing, while high-resolution computed tomography, brain natriuretic peptide and D-dimer are generally applied. High-dose steroids are widely administered (94%); the use of other immunosuppressant and treatment strategies is highly variable. Very few (4%) responders never use immunosuppression. Antifibrotic treatments are initiated during AE-IPF by 67%. Invasive ventilation or extracorporeal membrane oxygenation are mainly used as a bridge to transplantation. Most physicians educate patients comprehensively on the severity of AE-IPF (82%) and consider palliative care (64%).Approaches to the prevention, diagnosis and treatment of AE-IPF vary worldwide. Global trials and guidelines to improve the prognosis of AE-IPF are needed.</description><issn>0903-1936</issn><issn>1399-3003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo9kF1LwzAUhoMobk5_gSC59KbzJGdNW-_G8AsG3uh1SdOERdpmJq24f2-6Dy-SwMvz5nAeQm4ZzBnL8YFhUSAAzoFlAhIOrDgj0zFNxvicTKEATFiBYkKuQvgCYGKB7JJMkIMAEPmU1Es19JrqX6m0r2RvXUedoba2biv7jVV0OzSt66TfUWMr74INj9R2vfbdnpYNDYP_0Tsqu5oq2TTUOE830seWDXvmmlwY2QR9c3xn5PP56WP1mqzfX95Wy3WiMIU-MTnjiFJxlbFUVFqnigsQwtQKNOCCSc3jlWWyznNjYoCR5xVbCKUyRJyR-8O_W---Bx36srVB6aaRnXZDKDmmaTEeHlE8oCquFLw25dbbNm5ZMihHveVJb7nXW456Y-vuOGCoWl3_d04-8Q-k2XZb</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Kreuter, Michael</creator><creator>Polke, Markus</creator><creator>Walsh, Simon L F</creator><creator>Krisam, Johannes</creator><creator>Collard, Harold R</creator><creator>Chaudhuri, Nazia</creator><creator>Avdeev, Sergey</creator><creator>Behr, Jürgen</creator><creator>Calligaro, Gregory</creator><creator>Corte, Tamera</creator><creator>Flaherty, Kevin</creator><creator>Funke-Chambour, Manuela</creator><creator>Kolb, Martin</creator><creator>Kondoh, Yasuhiro</creator><creator>Maher, Toby M</creator><creator>Molina Molina, Maria</creator><creator>Morais, Antonio</creator><creator>Moor, Catharina C</creator><creator>Morisset, Julie</creator><creator>Pereira, Carlos</creator><creator>Quadrelli, Silvia</creator><creator>Selman, Moises</creator><creator>Tzouvelekis, Argyrios</creator><creator>Valenzuela, Claudia</creator><creator>Vancheri, Carlo</creator><creator>Vicens-Zygmunt, Vanesa</creator><creator>Wälscher, Julia</creator><creator>Wuyts, Wim</creator><creator>Wijsenbeek, Marlies</creator><creator>Cottin, Vincent</creator><creator>Bendstrup, Elisabeth</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5591-0955</orcidid><orcidid>https://orcid.org/0000-0003-3837-1467</orcidid><orcidid>https://orcid.org/0000-0001-8348-8651</orcidid><orcidid>https://orcid.org/0000-0001-7324-0775</orcidid><orcidid>https://orcid.org/0000-0002-1022-4783</orcidid><orcidid>https://orcid.org/0000-0001-9648-3497</orcidid></search><sort><creationdate>202004</creationdate><title>Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation</title><author>Kreuter, Michael ; Polke, Markus ; Walsh, Simon L F ; Krisam, Johannes ; Collard, Harold R ; Chaudhuri, Nazia ; Avdeev, Sergey ; Behr, Jürgen ; Calligaro, Gregory ; Corte, Tamera ; Flaherty, Kevin ; Funke-Chambour, Manuela ; Kolb, Martin ; Kondoh, Yasuhiro ; Maher, Toby M ; Molina Molina, Maria ; Morais, Antonio ; Moor, Catharina C ; Morisset, Julie ; Pereira, Carlos ; Quadrelli, Silvia ; Selman, Moises ; Tzouvelekis, Argyrios ; Valenzuela, Claudia ; Vancheri, Carlo ; Vicens-Zygmunt, Vanesa ; Wälscher, Julia ; Wuyts, Wim ; Wijsenbeek, Marlies ; Cottin, Vincent ; Bendstrup, Elisabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-f81233ac2c7156bee5c26066fdc0e0341ae241a77ad88ff34132332b146cc7333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kreuter, Michael</creatorcontrib><creatorcontrib>Polke, Markus</creatorcontrib><creatorcontrib>Walsh, Simon L F</creatorcontrib><creatorcontrib>Krisam, Johannes</creatorcontrib><creatorcontrib>Collard, Harold R</creatorcontrib><creatorcontrib>Chaudhuri, Nazia</creatorcontrib><creatorcontrib>Avdeev, Sergey</creatorcontrib><creatorcontrib>Behr, Jürgen</creatorcontrib><creatorcontrib>Calligaro, Gregory</creatorcontrib><creatorcontrib>Corte, Tamera</creatorcontrib><creatorcontrib>Flaherty, Kevin</creatorcontrib><creatorcontrib>Funke-Chambour, Manuela</creatorcontrib><creatorcontrib>Kolb, Martin</creatorcontrib><creatorcontrib>Kondoh, Yasuhiro</creatorcontrib><creatorcontrib>Maher, Toby M</creatorcontrib><creatorcontrib>Molina Molina, Maria</creatorcontrib><creatorcontrib>Morais, Antonio</creatorcontrib><creatorcontrib>Moor, Catharina C</creatorcontrib><creatorcontrib>Morisset, Julie</creatorcontrib><creatorcontrib>Pereira, Carlos</creatorcontrib><creatorcontrib>Quadrelli, Silvia</creatorcontrib><creatorcontrib>Selman, Moises</creatorcontrib><creatorcontrib>Tzouvelekis, Argyrios</creatorcontrib><creatorcontrib>Valenzuela, Claudia</creatorcontrib><creatorcontrib>Vancheri, Carlo</creatorcontrib><creatorcontrib>Vicens-Zygmunt, Vanesa</creatorcontrib><creatorcontrib>Wälscher, Julia</creatorcontrib><creatorcontrib>Wuyts, Wim</creatorcontrib><creatorcontrib>Wijsenbeek, Marlies</creatorcontrib><creatorcontrib>Cottin, Vincent</creatorcontrib><creatorcontrib>Bendstrup, Elisabeth</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The European respiratory journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kreuter, Michael</au><au>Polke, Markus</au><au>Walsh, Simon L F</au><au>Krisam, Johannes</au><au>Collard, Harold R</au><au>Chaudhuri, Nazia</au><au>Avdeev, Sergey</au><au>Behr, Jürgen</au><au>Calligaro, Gregory</au><au>Corte, Tamera</au><au>Flaherty, Kevin</au><au>Funke-Chambour, Manuela</au><au>Kolb, Martin</au><au>Kondoh, Yasuhiro</au><au>Maher, Toby M</au><au>Molina Molina, Maria</au><au>Morais, Antonio</au><au>Moor, Catharina C</au><au>Morisset, Julie</au><au>Pereira, Carlos</au><au>Quadrelli, Silvia</au><au>Selman, Moises</au><au>Tzouvelekis, Argyrios</au><au>Valenzuela, Claudia</au><au>Vancheri, Carlo</au><au>Vicens-Zygmunt, Vanesa</au><au>Wälscher, Julia</au><au>Wuyts, Wim</au><au>Wijsenbeek, Marlies</au><au>Cottin, Vincent</au><au>Bendstrup, Elisabeth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation</atitle><jtitle>The European respiratory journal</jtitle><addtitle>Eur Respir J</addtitle><date>2020-04</date><risdate>2020</risdate><volume>55</volume><issue>4</issue><spage>1901760</spage><pages>1901760-</pages><issn>0903-1936</issn><eissn>1399-3003</eissn><abstract>Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is an often deadly complication of IPF. No focussed international guidelines for the management of AE-IPF exist. The aim of this international survey was to assess the global variability in prevention, diagnostic and treatment strategies for AE-IPF.Pulmonologists with ILD expertise were invited to participate in a survey designed by an international expert panel.509 pulmonologists from 66 countries responded. Significant geographical variability in approaches to manage AE-IPF was found. Common preventive measures included antifibrotic drugs and vaccination. Diagnostic differences were most pronounced regarding use of Krebs von den Lungen-6 and viral testing, while high-resolution computed tomography, brain natriuretic peptide and D-dimer are generally applied. High-dose steroids are widely administered (94%); the use of other immunosuppressant and treatment strategies is highly variable. Very few (4%) responders never use immunosuppression. Antifibrotic treatments are initiated during AE-IPF by 67%. Invasive ventilation or extracorporeal membrane oxygenation are mainly used as a bridge to transplantation. Most physicians educate patients comprehensively on the severity of AE-IPF (82%) and consider palliative care (64%).Approaches to the prevention, diagnosis and treatment of AE-IPF vary worldwide. Global trials and guidelines to improve the prognosis of AE-IPF are needed.</abstract><cop>England</cop><pmid>32060068</pmid><doi>10.1183/13993003.01760-2019</doi><orcidid>https://orcid.org/0000-0002-5591-0955</orcidid><orcidid>https://orcid.org/0000-0003-3837-1467</orcidid><orcidid>https://orcid.org/0000-0001-8348-8651</orcidid><orcidid>https://orcid.org/0000-0001-7324-0775</orcidid><orcidid>https://orcid.org/0000-0002-1022-4783</orcidid><orcidid>https://orcid.org/0000-0001-9648-3497</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0903-1936 |
| ispartof | The European respiratory journal, 2020-04, Vol.55 (4), p.1901760 |
| issn | 0903-1936 1399-3003 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2355935592 |
| source | EZB-FREE-00999 freely available EZB journals |
| title | Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T08%3A01%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20exacerbation%20of%20idiopathic%20pulmonary%20fibrosis:%20international%20survey%20and%20call%20for%20harmonisation&rft.jtitle=The%20European%20respiratory%20journal&rft.au=Kreuter,%20Michael&rft.date=2020-04&rft.volume=55&rft.issue=4&rft.spage=1901760&rft.pages=1901760-&rft.issn=0903-1936&rft.eissn=1399-3003&rft_id=info:doi/10.1183/13993003.01760-2019&rft_dat=%3Cproquest_cross%3E2355935592%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2355935592&rft_id=info:pmid/32060068&rfr_iscdi=true |